Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978833 · ClinicalTrials.gov registry record · Phase 4
Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT02978833 is a Phase 4 study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 2 participants.
The verdict
NCT02978833, a Phase 4 study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
Gluteus medius tendinopathy, which is often referred to as Greater Trochanteric Pain Syndrome, is characterized by pain in the lateral aspect of the hip that is aggravated by side lying, stair climbing, and walking. Treatment is currently limited to lifestyle modifications, corticosteroid injections, physical therapy, and open and endoscopic surgical repair. Platelet rich plasma (PRP) injections contain important growth factors that are essential in the healing and tissue formation processes. However, the extent to which PRP is more efficacious than whole blood in tendinopathy remains unclear. In this double-blind randomized trial, patients will be allocated to receive either a PRP or whole-blood injection. Post-procedure assessments will occur at 6 weeks, 3 months, 6 months, 9 months, and 1 year.
Interventions
- DEVICE Ultrasound
- BIOLOGICAL PRP
- BIOLOGICAL Whole Blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-10-01 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02978833
The ClinicalTrials.gov registry entry for NCT02978833 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ultrasound is the first listed.
NCT02978833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02978833 about?
NCT02978833 is a clinical study titled "Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy". Gluteus medius tendinopathy, which is often referred to as Greater Trochanteric Pain Syndrome, is characterized by pain in the lateral aspect of the hip that is aggravated by side lying, stair climbing, and walking. Treatment is currently limited to lifestyle modifications, corticosteroid injections...
What is the current status of trial NCT02978833?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2013-10-01. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02978833?
The interventions under investigation include: Ultrasound (DEVICE), PRP (BIOLOGICAL), Whole Blood (BIOLOGICAL).
Who is sponsoring clinical trial NCT02978833?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.